These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25212850)

  • 1. Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.
    Fritschi SK; Langer F; Kaeser SA; Maia LF; Portelius E; Pinotsi D; Kaminski CF; Winkler DT; Maetzler W; Keyvani K; Spitzer P; Wiltfang J; Kaminski Schierle GS; Zetterberg H; Staufenbiel M; Jucker M
    Brain; 2014 Nov; 137(Pt 11):2909-2915. PubMed ID: 25212850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
    Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
    J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits.
    Anderson JJ; Holtz G; Baskin PP; Wang R; Mazzarelli L; Wagner SL; Menzaghi F
    Neuroscience; 1999; 93(4):1409-20. PubMed ID: 10501466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition.
    Langer F; Eisele YS; Fritschi SK; Staufenbiel M; Walker LC; Jucker M
    J Neurosci; 2011 Oct; 31(41):14488-95. PubMed ID: 21994365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
    Kane MD; Lipinski WJ; Callahan MJ; Bian F; Durham RA; Schwarz RD; Roher AE; Walker LC
    J Neurosci; 2000 May; 20(10):3606-11. PubMed ID: 10804202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy.
    Pitschke M; Prior R; Haupt M; Riesner D
    Nat Med; 1998 Jul; 4(7):832-4. PubMed ID: 9662376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
    Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
    J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.
    Pirttilä T; Mehta PD; Soininen H; Kim KS; Heinonen O; Paljärvi L; Kosunen O; Riekkinen P; Wisniewski HM
    Arch Neurol; 1996 Feb; 53(2):189-93. PubMed ID: 8639071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
    Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
    J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein.
    Pype S; Moechars D; Dillen L; Mercken M
    J Neurochem; 2003 Feb; 84(3):602-9. PubMed ID: 12558980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.
    Tabaton M; Nunzi MG; Xue R; Usiak M; Autilio-Gambetti L; Gambetti P
    Biochem Biophys Res Commun; 1994 May; 200(3):1598-603. PubMed ID: 8185615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
    Palmqvist S; Mattsson N; Hansson O;
    Brain; 2016 Apr; 139(Pt 4):1226-36. PubMed ID: 26936941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid.
    Schieb H; Kratzin H; Jahn O; Möbius W; Rabe S; Staufenbiel M; Wiltfang J; Klafki HW
    J Biol Chem; 2011 Sep; 286(39):33747-58. PubMed ID: 21795681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
    Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
    PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
    Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
    Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.